These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29360883)

  • 41. Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF).
    Goulart C; Rodriguez D; Kanno AI; Silva JLSC; Leite LCC
    Vaccine X; 2020 Apr; 4():100049. PubMed ID: 31891153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.
    Kono M; Hotomi M; Hollingshead SK; Briles DE; Yamanaka N
    PLoS One; 2011; 6(10):e27102. PubMed ID: 22073127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content.
    Figueiredo DB; Carvalho E; Santos MP; Kraschowetz S; Zanardo RT; Campani G; Silva GG; Sargo CR; Horta ACL; de C Giordano R; Miyaji EN; Zangirolami TC; Cabrera-Crespo J; Gonçalves VM
    Appl Microbiol Biotechnol; 2017 Mar; 101(6):2305-2317. PubMed ID: 27889801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.
    Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL
    Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.
    Lima FA; Ferreira DM; Moreno AT; Ferreira PC; Palma GM; Ferreira JM; Raw I; Miyaji EN; Ho PL; Oliveira ML
    Clin Vaccine Immunol; 2012 Sep; 19(9):1382-92. PubMed ID: 22761301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
    Hotomi M; Kono M; Hollingshead SK; Briles DE; Yamanaka N
    Adv Otorhinolaryngol; 2011; 72():121-5. PubMed ID: 21865708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcutaneous immunization with pneumococcal surface protein A in mice.
    Nagano H; Kawabata M; Sugita G; Tsuruhara A; Ohori J; Jimura T; Miyashita K; Kurono Y; Tomonaga K; Briles DE; Fujihashi K
    Laryngoscope; 2018 Mar; 128(3):E91-E96. PubMed ID: 29226330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infection.
    Wiedinger K; McCauley J; Bitsaktsis C
    Vaccine; 2020 Jul; 38(35):5634-5646. PubMed ID: 32646816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.
    Park SM; Ko HJ; Shim DH; Yang JY; Park YH; Curtiss R; Kweon MN
    J Immunol; 2008 Nov; 181(9):6447-55. PubMed ID: 18941235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.
    Ezoe H; Akeda Y; Piao Z; Aoshi T; Koyama S; Tanimoto T; Ishii KJ; Oishi K
    Vaccine; 2011 Feb; 29(9):1754-61. PubMed ID: 21219977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.
    Hsu CF; Hsiao CH; Tseng SF; Chen JR; Liao YJ; Chen SJ; Lin CS; Sytwu HK; Chuang YP
    Respir Res; 2018 Sep; 19(1):187. PubMed ID: 30253765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 54. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.
    Wu HY; Nahm MH; Guo Y; Russell MW; Briles DE
    J Infect Dis; 1997 Apr; 175(4):839-46. PubMed ID: 9086139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
    J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
    Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
    Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
    Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.
    Goulart C; da Silva TR; Rodriguez D; Politano WR; Leite LC; Darrieux M
    PLoS One; 2013; 8(3):e59605. PubMed ID: 23533636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.